Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

117 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Challenges in the development and reimbursement of personalized medicine-payer and manufacturer perspectives and implications for health economics and outcomes research: a report of the ISPOR personalized medicine special interest group.
Faulkner E, Annemans L, Garrison L, Helfand M, Holtorf AP, Hornberger J, Hughes D, Li T, Malone D, Payne K, Siebert U, Towse A, Veenstra D, Watkins J; Personalized Medicine Development and Reimbursement Working Group. Faulkner E, et al. Among authors: towse a. Value Health. 2012 Dec;15(8):1162-71. doi: 10.1016/j.jval.2012.05.006. Epub 2012 Sep 7. Value Health. 2012. PMID: 23244820 Free article.
The drug budget silo mentality in Europe: an overview.
Garrison L, Towse A. Garrison L, et al. Among authors: towse a. Value Health. 2003 Jul-Aug;6 Suppl 1:S1-9. doi: 10.1046/j.1524-4733.6.s1.1.x. Value Health. 2003. PMID: 12846921 Free article. Review. No abstract available.
Performance-based risk-sharing arrangements-good practices for design, implementation, and evaluation: report of the ISPOR good practices for performance-based risk-sharing arrangements task force.
Garrison LP Jr, Towse A, Briggs A, de Pouvourville G, Grueger J, Mohr PE, Severens JL, Siviero P, Sleeper M. Garrison LP Jr, et al. Among authors: towse a. Value Health. 2013 Jul-Aug;16(5):703-19. doi: 10.1016/j.jval.2013.04.011. Epub 2013 Jul 19. Value Health. 2013. PMID: 23947963 Free article.
The Expanding Value Footprint of Oncology Treatments.
Rejon-Parrilla JC, Hernández-Villafuerte K, Shah K, Mestre-Ferrandiz J, Garrison L, Towse A. Rejon-Parrilla JC, et al. Among authors: towse a. Value Health. 2014 Nov;17(7):A654. doi: 10.1016/j.jval.2014.08.2386. Epub 2014 Oct 26. Value Health. 2014. PMID: 27202367 Free article. No abstract available.
International Society for Pharmacoeconomics and Outcomes Research Comments on the American Society of Clinical Oncology Value Framework.
Malone DC, Berg NS, Claxton K, Garrison LP Jr, IJzerman M, Marsh K, Neumann PJ, Sculpher M, Towse A, Uyl-de Groot C, Weinstein MC. Malone DC, et al. Among authors: towse a. J Clin Oncol. 2016 Aug 20;34(24):2936-7. doi: 10.1200/JCO.2015.64.4328. Epub 2016 Jun 13. J Clin Oncol. 2016. PMID: 27298420 Free article. No abstract available.
117 results